- Home
- MCHX vs ADAG Comparison
MCHX vs ADAG Comparison
Compare MCHX & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- ADAG
- Stock Information
- Founded
- MCHX 2003
- ADAG 2011
- Country
- MCHX United States
- ADAG China
- Employees
- MCHX N/A
- ADAG N/A
- Industry
- MCHX Business Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- ADAG Health Care
- Exchange
- MCHX Nasdaq
- ADAG Nasdaq
- Market Cap
- MCHX 84.3M
- ADAG 81.9M
- IPO Year
- MCHX 2004
- ADAG 2021
- Fundamental
- Price
- MCHX $2.07
- ADAG $1.76
- Analyst Decision
- MCHX
- ADAG Strong Buy
- Analyst Count
- MCHX 0
- ADAG 1
- Target Price
- MCHX N/A
- ADAG $8.00
- AVG Volume (30 Days)
- MCHX 40.1K
- ADAG 153.3K
- Earning Date
- MCHX 03-13-2025
- ADAG 03-09-2025
- Dividend Yield
- MCHX N/A
- ADAG N/A
- EPS Growth
- MCHX N/A
- ADAG N/A
- EPS
- MCHX N/A
- ADAG N/A
- Revenue
- MCHX $48,594,000.00
- ADAG $815,746.00
- Revenue This Year
- MCHX N/A
- ADAG N/A
- Revenue Next Year
- MCHX $4.63
- ADAG $2.70
- P/E Ratio
- MCHX N/A
- ADAG N/A
- Revenue Growth
- MCHX N/A
- ADAG N/A
- 52 Week Low
- MCHX $1.11
- ADAG $1.64
- 52 Week High
- MCHX $2.40
- ADAG $3.65
- Technical
- Relative Strength Index (RSI)
- MCHX 60.01
- ADAG 42.36
- Support Level
- MCHX $1.88
- ADAG $1.64
- Resistance Level
- MCHX $2.04
- ADAG $1.95
- Average True Range (ATR)
- MCHX 0.09
- ADAG 0.10
- MACD
- MCHX 0.01
- ADAG 0.00
- Stochastic Oscillator
- MCHX 90.48
- ADAG 37.50
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.